Advertisement

Neurochemistry

Cellular, Molecular, and Clinical Aspects

  • Albert Teelken
  • Jaap Korf
Book

Table of contents

  1. Front Matter
    Pages i-xxvi
    PDF

  2. History of Neurochemistry

    1. Front Matter
      Pages 1-1
      PDF
    2. A Brief History of the European Society for Neurochemistry
      Herman Bachelard
      Pages 1-7
    3. Development of Neurochemical Research in the Ukraine
      A. V. Nazarenko, Ya. V. Belik
      Pages 9-12

  3. Clinical Aspects and Pathology

    1. Front Matter
      Pages 13-13
      PDF

    2. New Aspects of Alzheimer’s and Other Neurodegenerative Diseases

      1. Neuroinflammation and Alzheimer’s Disease
        P. Eikelenboom
        Pages 15-19
      2. Neurochemical Derangements and Cognitive Deficits in Apolipoprotein E Deficient Mice Following Closed Head Injury
        L. Lomnitski, Y. Chen, E. Shohami, R. Kohen, D. M. Michaelson
        Pages 21-26
      3. The Role of Cytokines in Alzheimer’s Disease
        M. Hüll, B. L. Fiebich, K. Lieb, B. Volk, M. Berger, J. Bauer
        Pages 27-32
      4. Profiles of Brain Phospholipids and Fatty Acids in Alzheimer’s Disease Brain
        E. Kienzl, K. Jellinger, L. Puchinger, B. M. Crandall, G. W. Arendash
        Pages 33-38
      5. Synaptic Pathology in Alzheimer’s Disease
        Pia Davidsson, Kaj Blennow
        Pages 39-46

    3. Antidepressant and Anxiolytic Mechanisms of Serotonergic Autoreceptor Agonists, Antagonists, and Reuptake Inhibitors

      1. 5-HT1A Partial Agonists as Anxiolytics and Antidepressants
        Jeffrey Sprouse
        Pages 47-53
      2. Effects of Repeated Administration of Dizocilpine on 5HT1A Receptor Binding in the Rat Brain
        S. Rump, I. Jakowicz
        Pages 55-57
      3. A Pharmacological Characterization Of Hippocampal 5-HT1D Receptors In The Guinea Pig
        S. K. Long, A. I. Bosch
        Pages 59-62
      4. Antidepressant Drug Actions on Hypothalamic-Pituitary-Adrenal Axis in Olfactory Bulbectomized Male Rats
        A. Marcilhac, G. Anglade, F. Hery, P. Siaud
        Pages 63-67
      5. Antagonist Affinity Estimates from Radioligand Binding and Functional Studies Vary at the Cloned Human 5-HT2C Receptor
        M. D. Wood, T. L. Gager, D. R. Thomas, V. L. Holland, A. M. Brown
        Pages 69-72

    4. Mild Hypothermia in the Management of Stroke and Other Ischemic Brain Trauma; Basic Mechanisms and Clinical Experience

      1. Glia and the Development of Brain Damage
        S. Knollema, S. V. van de Witte, G. J. Ter Horst
        Pages 73-78
      2. L-Deprenyl Reduces Brain Damage in the Caudate Putamen by a Mao-Dependent Effect
        S. Knollema, A. Wiersma, G. J. Ter Horst
        Pages 79-82
      3. Homeostatic Effects of Adenosine on Potentially Neurotoxic Glial Cell Activation
        Peter Schubert, Tadanori Ogata, Cristina Marchini, Kiyoshi Kataoka
        Pages 83-90
      4. Protective Effects of Mild Hypothermia on the Brain and Endothelium in Acute Embolic Stroke
        Hiroaki Naritomi, Takao Shimizu, Hidekazu Kinugawa, Tohru Sawada
        Pages 91-95
      5. Prevention of Cerebral Thermo-Pooling, Free Radical Reactions, and Protection of A10 Nervous System by Control of Brain Tissue Temperature in Severely Brain Injured Patients
        Nariyuki Hayashi, Kosaku Kinosita, Akira Utagawa, Nario Jo, Takeo Azuhata, Tadashi Shibuya
        Pages 97-103

    5. Neurochemistry and Neuroimmunology of EAE; Implications for Therapy of MS

      1. Experimental Allergic Encephalomyelitis
        Inge Huitinga, Jan Bauer, Sigrid R. Ruuls, Christine D. Dijkstra
        Pages 105-111
      2. Autoreactive T Lymphocytes in Multiple Sclerosis
        Piet Stinissen, Jingwu Zhang, Caroline Vandevyver, Jef Raus
        Pages 113-119
      3. Cytokines And Multiple Sclerosis
        B. W. van Oosten, C. H. Polman
        Pages 121-124
      4. N-3 Polyunsaturated Fatty Acids
        J. de Vries
        Pages 125-136
      5. Suppression of Experimental Autoimmune Encephalomyelitis in the Rat by Oral Administration of Spinal Cord Protein Hydrolysate
        B. Kwiatkowska-Patzer, B. Baranowska, M. Barcikowska-Litwin, A. W. Lipkowski
        Pages 137-140
      6. Selective Blood Brain Barrier Dysfunction After Intravenous Injections of RTNFα in the Rat
        Gert J. Ter Horst, Jan Gert Nagel, Mike J. L. De Jongste, Ysbrand D. Van der Werf
        Pages 141-146

    6. Neuroprotection in Model Studies for Dementia and Ischemia

      1. Hypoxia, Ca2+ Homeostasis, and Development and Aging of the Brain
        Csaba Nyakas, Bauke Buwalda, Paul G. M. Luiten
        Pages 147-152
      2. Glutamatergic Function in Alzheimer’s Disease
        Paul T. Francis, Sas N. Dijk
        Pages 153-159
      3. Morphochemical Changes in the Brain of Rats Under the Conditions of Dopamine System Dysfunction
        L. M. Gershtein, A. V. Sergutina
        Pages 161-164
      4. Neuroprotective Signal Transduction Pathways of sAPP and TNF
        Annadora J. Bruce, Katsutoshi Furukawa, Mark P. Mattson
        Pages 165-172
      5. Combined Fructose 1,6-Diphosphate-Dimethyl Sulfoxide Treatment Reverses Chronic Memory Deficits in Brain Ischemic Rats
        Jack C. de la Torre, Nancy Nelson, Robert J. Sutherland
        Pages 173-176
      6. Carnosine Protective Effect on Ischemic Brain in Vivo Study Using Proton Magnetic Resonance Spectroscopy
        D. Dobrota, I. Tkáè, V. Mlynárik, T. Liptaj, A. A. Boldyrev, S. L. Stvolinsky
        Pages 177-182
      7. A Magnetic Resonance Imaging Study of the Brain and the Spinal Cord During Ischemia
        D. Dobrota, I. Tkáè, V. Mlynárik, T. Liptaj
        Pages 183-186

    7. Pathogenic Mechanisms in Mood Disorders

      1. The Role of 5-Hydroxytryptamine in Depression
        G. Curzon
        Pages 187-191
      2. The Role of Noradrenaline in Depression and its Therapy
        Mike Briley, Chantal Moret
        Pages 193-196
      3. Monoaminergic and Glutamatergic Mechanisms in a Realistic Animal Model of Depression
        Mariusz Papp, Paul Willner
        Pages 197-200
      4. Effects of Ammonia and L-Tryptophan Loading on Brain Extracellular 5-HT and 5-HIAA Levels in Chronic Experimental Hepatic Encephalopathy
        Peter B. F. Bergqvist, Stephan Hjorth, Robert M. Audet, Gustav Apelqvist, Roger F. Butterworth, Finn Bengtsson
        Pages 201-207
      5. Dopamine Metabolism Trafficking in Genetically Defined Anxiety and Neuropathology
        N. K. Popova, D. F. Avgustinovich, E. M. Nikulina, J. A. Skrinskaya
        Pages 209-213

    8. Atypical Antipsychotics: The Neurochemical Relevance of Test Models

      1. Differential Effects of 2-(Ethylthio)Apomorphine Enantiomers on Striatal Dopamine Overflow in Vivo
        F. Auth, I. Laszlovszky, B. Kiss, E. Kárpáti, S. Berényi, Cs. Csutorás et al.
        Pages 215-219
      2. Neurosynaptic Nets and the Induction of Consciousness
        J. S. Wassenaar
        Pages 221-225

    9. Signalling and Myelin Gene Regulation during Development and Regeneration

      1. Oligodendrocytes and Schwann Cells Respond Differently to a Transgene Induced Reduction of Axon Caliber
        Joël Eyer, Alan Peterson
        Pages 227-232
      2. Major Myelin Specific Genes Expression in pt PLP Gene Mutant Rabbit
        Joanna Sypecka, Krystyna Domañska-Janik
        Pages 233-237
      3. Growth Regulation and Myelin Protein Expression in a Newly Established Permanent Glial Cell Line
        C. Richter-Landsberg, W. Hoppenstedt
        Pages 239-242

    10. Aspects of Pathogenesis and Therapy of Parkinson’s Disease

      1. The Role of Glutathione in the Pathogenesis of Parkinson’s Disease
        B. Drukarch, J. C. Stoof
        Pages 243-248
      2. Sources of Cells for Transplantation and Gene Therapy in Parkinson’s Disease
        S. B. Dunnett, L. E. Annett, A. L. Kendall, A. E. Rosser, C. Watts, C. N. Svendsen
        Pages 249-257
      3. Characterization of a Signalling Pathway Underlying Neuronal Cell Death After Trophic Support Withdrawal Or TNFα Treatment
        Nathalie Lambeng, Valentine France-Lanord, Bernard Brugg, Philippe Anglade, Patrick P. Michel, Yves Agid et al.
        Pages 259-263

    11. Neurochemistry of Epilepsy

      1. Autoantibodies Against Human Brain AMPA/Quisqualate Receptor Capable of Determining Persons with Brain Paroxysmal Activity and Epilepsy
        S. A. Dambinova, L. G. Gromova
        Pages 265-274
      2. GABA-Dependent Modulation of [3H]TBOB Binding to the GABAA Receptor Complex
        Clementina M. van Rijn, Ris Dirksen, Jan Pieter C. Zwart, Elly Willems-van Bree
        Pages 275-279
      3. Increased Incidence of CNS- and Phospholipid Antibodies in Epileptic Syndromes of Childhood
        W. Diener, R. Klein, K. Kast, U. Danneberg, M. Mohrmann, P. A. Berg et al.
        Pages 281-286
      4. Effect of Some Neuropeptides on MAO Activity Under Experimental Epilepsy
        E. L. Dovedova
        Pages 287-289

About this book

Keywords

Alzheimer Nervous System alzheimer's disease brain dementia metabolism neurochemistry neuroprotection neurotransmitter protein receptor stroke trauma

Editors and affiliations

  • Albert Teelken
    • 1
  • Jaap Korf
    • 1
  1. 1.University HospitalGroningenThe Netherlands

Bibliographic information